Alliance for Clinical Trials in Oncology
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 2011-01-01
- Employees
- 251
- Market Cap
- -
Vinorelbine in Treating Older Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer
- First Posted Date
- 2004-02-03
- Last Posted Date
- 2016-07-13
- Lead Sponsor
- Alliance for Clinical Trials in Oncology
- Target Recruit Count
- 59
- Registration Number
- NCT00008333
- Locations
- 🇺🇸
Siouxland Hematology-Oncology, Sioux City, Iowa, United States
🇺🇸CCOP - Geisinger Clinic and Medical Center, Danville, Pennsylvania, United States
🇺🇸CCOP - Cedar Rapids Oncology Project, Cedar Rapids, Iowa, United States
506U78 in Treating Patients With Hematologic Cancer and Kidney or Liver Impairment
- Conditions
- Chronic Myeloproliferative DisordersLeukemiaLymphomaMultiple Myeloma and Plasma Cell NeoplasmMyelodysplastic Syndromes
- Interventions
- Drug: Compound 506U78
- First Posted Date
- 2004-01-29
- Last Posted Date
- 2016-07-04
- Lead Sponsor
- Alliance for Clinical Trials in Oncology
- Target Recruit Count
- 10
- Registration Number
- NCT00004239
- Locations
- 🇺🇸
Comprehensive Cancer Center at Wake Forest University, Winston-Salem, North Carolina, United States
🇺🇸Holden Comprehensive Cancer Center at The University of Iowa, Iowa City, Iowa, United States
🇺🇸University of Chicago Cancer Research Center, Chicago, Illinois, United States
Irinotecan in Treating Patients With Advanced Cancer of the Stomach
- Conditions
- Gastric CancerEsophageal Cancer
- Interventions
- First Posted Date
- 2004-01-22
- Last Posted Date
- 2016-07-14
- Lead Sponsor
- Alliance for Clinical Trials in Oncology
- Target Recruit Count
- 70
- Registration Number
- NCT00003137
- Locations
- 🇺🇸
Mayo Clinic Jacksonville, Jacksonville, Florida, United States
🇺🇸CCOP - Cedar Rapids Oncology Project, Cedar Rapids, Iowa, United States
🇺🇸CCOP - Illinois Oncology Research Association, Peoria, Illinois, United States
Low-Dose Testosterone in Improving Libido in Postmenopausal Female Cancer Survivors
- Conditions
- Cancer SurvivorSexual DysfunctionSexuality and Reproductive IssuesUnspecified Adult Solid Tumor, Protocol Specific
- Interventions
- Other: placebo
- First Posted Date
- 2004-01-13
- Last Posted Date
- 2016-07-13
- Lead Sponsor
- Alliance for Clinical Trials in Oncology
- Target Recruit Count
- 150
- Registration Number
- NCT00075855
- Locations
- 🇺🇸
Siouxland Hematology-Oncology, Sioux City, Iowa, United States
🇺🇸Medcenter One Health System, Bismarck, North Dakota, United States
🇺🇸CCOP - Geisinger Clinic and Medical Center, Danville, Pennsylvania, United States
(Valerian) for Improving Sleep in Patients With Cancer Receiving Adjuvant Therapy
- Conditions
- Unspecified Adult Solid Tumor, Protocol SpecificSleep DisordersFatigue
- Interventions
- Dietary Supplement: Valeriana officinalis extractOther: placebo
- First Posted Date
- 2004-01-13
- Last Posted Date
- 2016-12-06
- Lead Sponsor
- Alliance for Clinical Trials in Oncology
- Target Recruit Count
- 227
- Registration Number
- NCT00075842
- Locations
- 🇺🇸
Fairview Southdale Hospital, Edina, Minnesota, United States
🇺🇸St. Mary - Corwin Regional Medical Center, Pueblo, Colorado, United States
🇺🇸Virginia Piper Cancer Institute at Abbott - Northwestern Hospital, Minneapolis, Minnesota, United States
Combination Chemotherapy in Treating Patients With Unresectable or Metastatic Biliary Tract or Gallbladder Cancer
- Conditions
- Liver CancerExtrahepatic Bile Duct CancerGallbladder Cancer
- Interventions
- First Posted Date
- 2004-01-01
- Last Posted Date
- 2016-12-07
- Lead Sponsor
- Alliance for Clinical Trials in Oncology
- Target Recruit Count
- 42
- Registration Number
- NCT00009893
- Locations
- 🇺🇸
CCOP - Carle Cancer Center, Urbana, Illinois, United States
🇺🇸Siouxland Hematology-Oncology, Sioux City, Iowa, United States
🇺🇸Medcenter One Health System, Bismarck, North Dakota, United States
Docetaxel and Carboplatin in Treating Women With Metastatic Breast Cancer
- First Posted Date
- 2003-12-23
- Last Posted Date
- 2016-12-07
- Lead Sponsor
- Alliance for Clinical Trials in Oncology
- Target Recruit Count
- 53
- Registration Number
- NCT00005963
- Locations
- 🇺🇸
CCOP - Duluth, Duluth, Minnesota, United States
🇺🇸Siouxland Hematology-Oncology, Sioux City, Iowa, United States
🇺🇸CentraCare Clinic, Saint Cloud, Minnesota, United States
Paclitaxel in Treating Patients With Extensive-Stage Small Cell Lung Cancer
- First Posted Date
- 2003-12-17
- Last Posted Date
- 2016-07-14
- Lead Sponsor
- Alliance for Clinical Trials in Oncology
- Target Recruit Count
- 36
- Registration Number
- NCT00005646
- Locations
- 🇺🇸
Medical University of South Carolina, Charleston, South Carolina, United States
🇺🇸State University of New York - Upstate Medical University, Syracuse, New York, United States
🇺🇸Ellis Fischel Cancer Center - Columbia, Columbia, Missouri, United States
Fludarabine Followed by Alemtuzumab in Treating Patients With Chronic Lymphocytic Leukemia
- First Posted Date
- 2003-12-11
- Last Posted Date
- 2016-07-06
- Lead Sponsor
- Alliance for Clinical Trials in Oncology
- Target Recruit Count
- 86
- Registration Number
- NCT00004857
- Locations
- 🇺🇸
University of Illinois at Chicago Health Sciences Center, Chicago, Illinois, United States
🇺🇸Veterans Affairs Medical Center - Chicago (Westside Hospital), Chicago, Illinois, United States
🇺🇸University of Chicago Cancer Research Center, Chicago, Illinois, United States
Pentostatin in Treating Patients With Refractory Chronic Graft-Versus-Host Disease
- First Posted Date
- 2003-12-11
- Last Posted Date
- 2021-11-03
- Lead Sponsor
- Alliance for Clinical Trials in Oncology
- Target Recruit Count
- 39
- Registration Number
- NCT00074035
- Locations
- 🇺🇸
University of Illinois Cancer Center, Chicago, Illinois, United States
🇺🇸Western Pennsylvania Cancer Institute at Western Pennsylvania Hospital, Pittsburgh, Pennsylvania, United States
🇺🇸Tunnell Cancer Center at Beebe Medical Center, Lewes, Delaware, United States